Global Peptic Ulcer Drugs Market 2014-2018: Key Vendors are AstraZeneca, Eisai, Daewoong and Takeda

Research and Markets (http://www.researchandmarkets.com/research/jjj5vs/global_peptic) has announced the addition of the "Global Peptic Ulcer Drugs Market 2014-2018" report to their offering. A peptic ulcer is an open lesion that develops on the mucosal lining of the stomach and small intestine because of the caustic effect of the gastric acids and enzymes in these organs. The symptoms of peptic ulcers are pain in the abdomen, nausea, vomiting, and bloated stomach. The major symptoms include bleeding from the ulcer, which can be life-threatening. It is detected by bloody and sticky stools, often black in color. Peptic ulcers are caused mainly by a Helicobacter pylori infection followed by the overuse of OTC NSAIDs such as Naproxen, Aspirin and Ibuprofen. Peptic ulcers can be of two types based on the site of the ulcer: gastric ulcer and duodenal ulcer. The analysts forecast the Global Peptic Ulcer Drugs market to grow at a CAGR of 2.9 percent over the period 2013-2018. This report covers the present scenario and the growth prospects of the Global Peptic Ulcer Drugs market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of peptic ulcers that are available in the market.

Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Product Profiles 05. Market Research Methodology 06. Introduction 07. Market Landscape 08. Pipeline Portfolio 09. Market Segmentation by Class of Drugs 10. Geographical Segmentation 11. Buying Criteria 12. Market Growth Drivers 13. Drivers and their Impact 14. Market Challenges 15. Impact of Drivers and Challenges 16. Market Trends 17. Trends and their Impact 18. Vendor Landscape 19. Key Vendor Analysis

Companies Mentioned:

AstraZeneca plc
Eisai Co. Ltd.
Daewoong Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co. Ltd.
Daiichi Sankyo
Dr. Reddy's Laboratories
Eumedica
Ferring Pharmaceuticals
Horizon Pharma
Johnson and Johnson
Merck Sharp and Dohme
Otsuka Holdings
Pfizer
PharmaKing
Pozen
Rottapharm Madaus
Taiho Pharmaceutical
Zeria Pharmaceutical and Zuventus Healthcare

For more information visit http://www.researchandmarkets.com/research/jjj5vs/global_peptic

Media Contact: Laura Wood , +353-1-481-1716, [email protected]

SOURCE Research and Markets

Latest Press Release on Corporate News

KPJ Pasir Gudang Specialist Hospital Partners with NetSfere for Secure and Compliant Messaging

CHICAGO, March 26, 2024 (GLOBE NEWSWIRE) -- NetSfere , a global provider of next-generation secure and compliant messaging and mobility solutions, today announces that KPJ Pasir Gud...

Philips convenes the Annual General Meeting of Shareholders 2024

March 22, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced it has convened the Annual General Meeting of Shareholders (AGM) 2024 and pu...

Amlan International Forges Strategic Partnership with Grupo Profil as its Newest Latin American Distributor, Amplifying Access to Innovative Gut Health Solutions for Protein Producers

CHICAGO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Amlan ® International, the animal health division of Oil-Dri ® Corporation of America, is excited to announce its partnership with Grupo P...

Impulse Dynamics Completes $136M Financing Round

Marlton, NJ, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart failure (HF), is proud to an...

Global Healthcare E-commerce Market to Accrue $1038.17 Billion by 2030, Registering a Robust 19.93% CAGR, Propelled by Rising Adoption of Online Healthcare Solutions, States Kings Research

DUBAI , UAE , Feb. 13, 2024 /PRNewswire/ -- According to a recent Kings Research study, the global Healthcare E-c ommerce Market was valued at USD 244.99 billion in 2022...